Laguna Hills, CA - October 21,2014 - InvestorsHub NewsWire
- Itonis, Inc. (OTC
PINKSHEETS: ITNS) is pleased to announce that it has
launched its www.emesyl.com website in preparation for the release
of its new Emesyl® homeopathic product for nausea relief, with a
new and improved packaging design.
On September 12, 2014, after Itonis received the first batch of
Emesyl® from its manufacturer and released a photograph showing the
original Emesyl® packaging design, Itonis’ executive team
immediately decided to modify the Emesyl® packaging to better
convey the product message and to drive marketing and ultimate
sales.
“We had an opportunity to interrupt the full completion of
Emesyl® to improve the packaging in the long-run for marketing
purposes and to achieve sales,” said Mark Cheung, Itonis’ CEO, “so
we immediately instituted design changes that can be viewed at
www.emesyl.com. While we acknowledge the delay,
we believe that the immediate box modification was a necessity that
minimized further expenses while gaining an improved packaging
design that would better deliver retail marketing advantages.”
The Company is also pleased to share that, with the originally
delivered Emesyl®, it has obtained letters of intent with
distributors, and is negotiating the final distribution
agreements. Please stay tuned for further distribution
updates.
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by
Charles Hensley, Ph.D., and its mission is to create and market
over-the-counter and prescription homeopathic products that better
people's lives. Dr. Hensley is a pioneer in the development and
marketing of safe and effective therapeutic nutraceutical and
homeopathic preparations. He was a founder of the company
that launched the Zicam® Cold Remedy, making the product a
household name and forever changing the marketing and product
placement paradigm for homeopathic drugs in the United
States. Dr. Hensley and his team plan to use the same
methodologies to revolutionize the treatment of several other
common ailments and other chronic diseases.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis
Inc. has focused on transitioning itself in the past year from
acquiring high growth, market niche entrepreneurial companies, to a
market leader focused on the distribution of innovative products to
the medical and pharmaceutical industry. Please visit www.itonisholdings.com.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact:
Itonis, Inc.
Office@itonisholdings.com
